BIOMAT Database Logo BIOMAT Database Logo

Low-dose and high-dose radioiodine in thyroid cancer. 1977

U Y Ryo

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm

Related Publications

U Y Ryo
[Low-dose Radioiodine for Ablation in Non-metastatic High-risk Thyroid Cancer].
October 2015, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
U Y Ryo
High or low dose radioiodine ablation of thyroid remnants?
January 1987, European journal of nuclear medicine,
U Y Ryo
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.
May 2012, The New England journal of medicine,
U Y Ryo
Low-Dose Radioiodine Ablation in Patients with Low-Risk Differentiated Thyroid Cancer.
August 2018, European thyroid journal,
U Y Ryo
Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer.
February 2020, Annals of nuclear medicine,
U Y Ryo
Low- and high-dose radioiodine therapy for low-/intermediate-risk differentiated thyroid cancer: a preliminary clinical trial.
January 2017, Annals of nuclear medicine,
U Y Ryo
Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in patients with intermediate-risk differentiated thyroid cancer.
March 2017, Nuclear medicine communications,
U Y Ryo
Low- and high-dose radioiodine ablation for low-/intermediate-risk differentiated thyroid cancer in China: Large randomized clinical trial.
April 2021, Head & neck,
U Y Ryo
Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.
November 1985, Clinical nuclear medicine,
U Y Ryo
Radioiodine ablation in low-risk thyroid cancer.
August 2012, The New England journal of medicine,
Copied contents to your clipboard!